Benchmark Holdings Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
570
- Stock Symbol
-
BMK
- Investments
-
16
- Share Price
-
$0.44
- (As of Friday Closing)
Benchmark Holdings General Information
Description
Benchmark Holdings PLC is engaged in the healthcare sector in the United Kingdom. Its operating segment includes Genetics; advanced Nutrition; Health; All other segments and Corporate. The company generates maximum revenue from the advanced Nutrition segment. The advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the global aquaculture industry. Geographically, it derives a majority of its revenue from the Rest of the World and also has a presence in Norway; the Faroe Islands; Ecuador; India; Greece; Singapore; Chile, and the Rest of Europe.
Contact Information
- 4 Park Square, Thorncliffe Park
- Chapeltown
- Sheffield S35 2PH
- England, United Kingdom
Benchmark Holdings Timeline
Benchmark Holdings Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.44 | $0.46 | $0.40 - $0.59 | $327M | 739M | 94.3K | -$0.04 |
Benchmark Holdings Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2023 | FY 2023 30-Sep-2023 | FY 2022 30-Sep-2022 | FY 2021 30-Sep-2021 |
|---|---|---|---|---|
| EV | 427,093 | 427,093 | 427,437 | 664,842 |
| Revenue | 207,572 | 207,572 | 202,049 | 171,023 |
| EBITDA | 41,460 | 41,460 | 34,439 | 31,948 |
| Net Income | (28,349) | (28,349) | (40,961) | (17,628) |
| Total Assets | 575,031 | 575,031 | 588,021 | 647,166 |
| Total Debt | 124,450 | 124,450 | 122,988 | 161,649 |
Benchmark Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Benchmark Holdings Executive Team (12)
Benchmark Holdings Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Malcolm Pye | Benchmark Holdings | Founder | 000 0000 |
| Peter George | Benchmark Holdings | Chairman & Board Member | 000 0000 |
| Septima Maguire | Benchmark Holdings | Chief Financial Officer, Finance & Board Member | 000 0000 |
| Susan Searle | Self | Board Member | 000 0000 |
| Trond Williksen | Benchmark Holdings | Chief Executive Officer & Board Member | 000 0000 |
Benchmark Holdings Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Benchmark Holdings Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Benchmark Holdings Investments & Acquisitions (16)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| StofnFiskur | 17-Feb-2023 | 0000000000 | 000.00 | Food Products | |
| Benchmark Genetics Chile | 10-Jun-2019 | 0000000000 | 000.00 | Aquaculture | |
| Videntis | 03-Oct-2018 | 0000000000 | 00000 | Aquaculture | |
| Benchmark Genetics Chile | 08-Jun-2018 | 00000 0000 | Aquaculture | ||
| Salmones Chaicas | 08-Jun-2018 | Secondary Transaction - Private | Food Products |
Benchmark Holdings Subsidiaries (8)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Tomalgae | Biotechnology | Nevele, Belgium | 2013 |
| Benchmark Genetics | Aquaculture | Bergen, Norway | 0000 |
| SalmoBreed | Other Consumer Non-Durables | Bergen, Norway | 0000 |
| 5M Books | Publishing | Great Easton, United Kingdom | 0000 |
| Inve Technologies NV | Distributors/Wholesale | Dendermonde, Belgium | 0000 |
Benchmark Holdings ESG
Risk Overview
Risk Rating
Updated March, 29, 2020
52.92 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
0.000
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 10,573
Rank
Percentile
Pharmaceuticals
Industry
00 of 709
Rank
Percentile
Pharmaceuticals
Subindustry
00 of 247
Rank
Percentile
Benchmark Holdings Exits (3)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Benchmark Genetics | 27-Jul-2015 | 000000000000000000 | 00.00 | Completed |
|
| Improve Veterinary Education | 02-Feb-2015 | 000000000000000000 | 00.00 | Completed |
|
| Fish Vet Group | 01-Jul-2004 | Merger/Acquisition | Completed |